Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R E Vestal

Showing results (1-10 of 113) with videos related to

Pageof 12
Sort By:
Hepatology (Baltimore, Md.)|February 1, 1989
Aging and determinants of hepatic drug clearanceR E Vestal
Clinical Pharmacology and Therapeutics|May 30, 1998
Notes of the American Society for Clinical Pharmacology and Therapeutics. A letter to the membersR E Vestal
Clinical Pharmacology and Therapeutics|December 2, 1998
The clinical pharmacologist: an endangered species?R E Vestal
Cancer|October 8, 1997
Aging and pharmacologyR E Vestal
Geriatrics|June 1, 1983
Should digitalis be used in elderly patients?R E Vestal
Drugs|October 1, 1978
Drug use in the elderly: a review of problems and special considerationsR E Vestal
Journal of Clinical Pharmacology|April 1, 1996
Clinical pharmacology: present status and projections for the futureR E Vestal
Clinical Pharmacology and Therapeutics|November 14, 1997
Geriatric clinical pharmacologist and medical oncologist: a new partnership?R E Vestal, P Calabresi
British Journal of Pharmacology|July 1, 1989
Effects of adenosine on polymorphonuclear leucocyte function, cyclic 3': 5'-adenosine monophosphate, and intracellular calciumC P Nielson, R E Vestal
Journal of Clinical Pharmacology|September 1, 1992
Workshop on problem-based learning as a method for teaching clinical pharmacology and therapeutics in medical schoolR E Vestal, N L Benowitz
Pageof 12

Showing results (1-10 of 113) with videos related to

Sort By:
Pageof 12
Hepatology (Baltimore, Md.)|February 1, 1989
Aging and determinants of hepatic drug clearanceR E Vestal
Clinical Pharmacology and Therapeutics|May 30, 1998
Notes of the American Society for Clinical Pharmacology and Therapeutics. A letter to the membersR E Vestal
Clinical Pharmacology and Therapeutics|December 2, 1998
The clinical pharmacologist: an endangered species?R E Vestal
Cancer|October 8, 1997
Aging and pharmacologyR E Vestal
Geriatrics|June 1, 1983
Should digitalis be used in elderly patients?R E Vestal
Drugs|October 1, 1978
Drug use in the elderly: a review of problems and special considerationsR E Vestal
Journal of Clinical Pharmacology|April 1, 1996
Clinical pharmacology: present status and projections for the futureR E Vestal
Clinical Pharmacology and Therapeutics|November 14, 1997
Geriatric clinical pharmacologist and medical oncologist: a new partnership?R E Vestal, P Calabresi
British Journal of Pharmacology|July 1, 1989
Effects of adenosine on polymorphonuclear leucocyte function, cyclic 3': 5'-adenosine monophosphate, and intracellular calciumC P Nielson, R E Vestal
Journal of Clinical Pharmacology|September 1, 1992
Workshop on problem-based learning as a method for teaching clinical pharmacology and therapeutics in medical schoolR E Vestal, N L Benowitz
Pageof 12